1.Erratum: Korean Practice Guidelines for Gastric Cancer 2022: An Evidencebased, Multidisciplinary Approach
Tae-Han KIM ; In-Ho KIM ; Seung Joo KANG ; Miyoung CHOI ; Baek-Hui KIM ; Bang Wool EOM ; Bum Jun KIM ; Byung-Hoon MIN ; Chang In CHOI ; Cheol Min SHIN ; Chung Hyun TAE ; Chung sik GONG ; Dong Jin KIM ; Arthur Eung-Hyuck CHO ; Eun Jeong GONG ; Geum Jong SONG ; Hyeon-Su IM ; Hye Seong AHN ; Hyun LIM ; Hyung-Don KIM ; Jae-Joon KIM ; Jeong Il YU ; Jeong Won LEE ; Ji Yeon PARK ; Jwa Hoon KIM ; Kyoung Doo SONG ; Minkyu JUNG ; Mi Ran JUNG ; Sang-Yong SON ; Shin-Hoo PARK ; Soo Jin KIM ; Sung Hak LEE ; Tae-Yong KIM ; Woo Kyun BAE ; Woong Sub KOOM ; Yeseob JEE ; Yoo Min KIM ; Yoonjin KWAK ; Young Suk PARK ; Hye Sook HAN ; Su Youn NAM ; Seong-Ho KONG
Journal of Gastric Cancer 2023;23(2):365-373
		                        		
		                        		
		                        		
		                        	
2.Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
Tae-Han KIM ; In-Ho KIM ; Seung Joo KANG ; Miyoung CHOI ; Baek-Hui KIM ; Bang Wool EOM ; Bum Jun KIM ; Byung-Hoon MIN ; Chang In CHOI ; Cheol Min SHIN ; Chung Hyun TAE ; Chung sik GONG ; Dong Jin KIM ; Arthur Eung-Hyuck CHO ; Eun Jeong GONG ; Geum Jong SONG ; Hyeon-Su IM ; Hye Seong AHN ; Hyun LIM ; Hyung-Don KIM ; Jae-Joon KIM ; Jeong Il YU ; Jeong Won LEE ; Ji Yeon PARK ; Jwa Hoon KIM ; Kyoung Doo SONG ; Minkyu JUNG ; Mi Ran JUNG ; Sang-Yong SON ; Shin-Hoo PARK ; Soo Jin KIM ; Sung Hak LEE ; Tae-Yong KIM ; Woo Kyun BAE ; Woong Sub KOOM ; Yeseob JEE ; Yoo Min KIM ; Yoonjin KWAK ; Young Suk PARK ; Hye Sook HAN ; Su Youn NAM ; Seong-Ho KONG ;
Journal of Gastric Cancer 2023;23(1):3-106
		                        		
		                        			
		                        			 Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group including experts in the field of gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology and guideline development methodology. Total of 33 key questions were updated or proposed after a collaborative review by the working group and 40 statements were developed according to the systematic review using the MEDLINE, Embase, Cochrane Library and KoreaMed database. The level of evidence and the grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation proposition. Evidence level, benefit, harm, and clinical applicability was considered as the significant factors for recommendation. The working group reviewed recommendations and discussed for consensus. In the earlier part, general consideration discusses screening, diagnosis and staging of endoscopy, pathology, radiology, and nuclear medicine. Flowchart is depicted with statements which is supported by meta-analysis and references. Since clinical trial and systematic review was not suitable for postoperative oncologic and nutritional follow-up, working group agreed to conduct a nationwide survey investigating the clinical practice of all tertiary or general hospitals in Korea. The purpose of this survey was to provide baseline information on follow up. Herein we present a multidisciplinary-evidence based gastric cancer guideline. 
		                        		
		                        		
		                        		
		                        	
3.Direct Internal Fixation for Unstable Atlas Fractures
Jae-Won SHIN ; Kyung-Soo SUK ; Hak-Sun KIM ; Jae-Ho YANG ; Ji-Won KWON ; Hwan-Mo LEE ; Sung-Hwan MOON ; Byung-Ho LEE ; Sang-Jun PARK ; Sub-ri PARK ; Sun-kyu KIM
Yonsei Medical Journal 2022;63(3):265-271
		                        		
		                        			 Purpose:
		                        			To investigate the radiologic and clinical outcomes of direct internal fixation for unstable atlas fractures. 
		                        		
		                        			Materials and Methods:
		                        			This retrospective study included 12 patients with unstable atlas fractures surgically treated using C1 lateral mass screws, rods, and transverse connector constructs. Nine lateral mass fractures with transverse atlantal ligament (TAL) avulsion injury and three 4-part fractures with TAL injury (two avulsion injuries, one TAL substance tear) were treated. Radiologic outcomes included the anterior atlantodental interval (AADI) in flexion and extension cervical spine lateral radiographs at 6 months and 1 year after treatment. CT was also performed to visualize bony healing of the atlas at 6 months and 1 year. Visual Analog Scale (VAS) scores for neck pain, Neck Disability Index (NDI) values, and cervical range of motion (flexion, extension, and rotation) were recorded at 6 months after surgery. 
		                        		
		                        			Results:
		                        			The mean postoperative extension and flexion AADIs were 3.79±1.56 (mean±SD) and 3.13±1.01 mm, respectively. Then mean AADI was 3.42±1.34 and 3.33±1.24 mm at 6 months and 1 year after surgery, respectively. At 1 year after surgery, 11 patients showed bony healing of the atlas on CT images. Only one patient underwent revision surgery 8 months after primary surgery due to nonunion and instability findings. The mean VAS score for neck pain was 0.92±0.99, and the mean NDI value was 8.08±5.70. 
		                        		
		                        			Conclusion
		                        			C1 motion-preserving direct internal fixation technique results in good reduction and stabilization of unstable atlas fractures. This technique allows for the preservation of craniocervical and atlantoaxial motion. 
		                        		
		                        		
		                        		
		                        	
4.Clinical Outcomes of Immune Checkpoint Blocker Therapy for Malignant Melanoma in Korean Patients: Potential Clinical Implications for a Combination Strategy Involving Radiotherapy
Jeongshim LEE ; Jee Suk CHANG ; Mi Ryung ROH ; Minkyu JUNG ; Choong-Kun LEE ; Byung Ho OH ; Kee Yang CHUNG ; Woong Sub KOOM ; Sang Joon SHIN
Cancer Research and Treatment 2020;52(3):730-738
		                        		
		                        			 Purpose:
		                        			We investigated the clinical efficacy of immune checkpoint blocker (ICB) therapy for metastatic or advanced melanoma in Korean patients. As well, we assessed whether the effects of ICBs can be enhanced by combination therapy with palliative radiotherapy (RT). 
		                        		
		                        			Materials and Methods:
		                        			We retrospectively reviewed the records of 127 patients with metastatic melanoma who received ICB with or without palliative RT between 2014 and 2018. The melanoma subtypes were classified as follows: chronic sun-damaged (CSD), acral, mucosal, and uveal. The primary endpoint was the objective response rate (ORR). 
		                        		
		                        			Results:
		                        			The overall ORR was 15%, with 11 complete and eight partial responses. ORRs for CSD, acral/mucosal, and uveal melanomas were 50%, 16.5%, and 0%, respectively (p=0.009). In addition to the subtype, stage at treatment, total tumor burden at treatment, and ICB type were significantly associated with ORR (all p < 0.05). Palliative RT was administered in 44% of patients during the treatment, and it did not affect ORR. Clinical responders to ICB therapy exhibited significantly higher 1-year progression-free and overall survival rates than nonresponders. 
		                        		
		                        			Conclusion
		                        			ORR for ICB monotherapy in Korean patients with melanoma is relatively modest compared with that in Western patients because the non-CSD subtypes are predominant in the Korean population. Our findings regarding combination therapy with ICB provided a rationale for the initiation of our phase II study (NCT04017897). 
		                        		
		                        		
		                        		
		                        	
5.First Blindness Cases of Horses Infected with Setaria Digitata (Nematoda: Filarioidea) in the Republic of Korea.
Jihun SHIN ; Kyu Sung AHN ; Guk Hyun SUH ; Ha Jung KIM ; Hak Sub JEONG ; Byung Su KIM ; Eunsang CHOI ; Sung Shik SHIN
The Korean Journal of Parasitology 2017;55(6):667-671
		                        		
		                        			
		                        			Ocular setariases of cattle were reported but those of equine hosts have never been reported in the Republic of Korea (Korea). We found motile worms in the aqueous humor of 15 horses (Equus spp.) from 12 localities in southern parts of Korea between January 2004 and November 2017. After the affected animals were properly restrained under sedation and local anesthesia, 10 ml disposable syringe with a 16-gauge needle was inserted into the anterior chamber of the affected eye to successfully remove the parasites. The male worm that was found in 7 of the cases showed a pair of lateral appendages near the posterior terminal end of the body. The papillar arrangement was 3 pairs of precloacal, a pair of adcloacal, and 3 pairs of postcloacal papillae, plus a central papilla just in front of the cloaca. The female worms found in the eyes of 8 horses were characterized by the tapering posterior terminal end of the body with a smooth knob. Worms were all identified as Setaria digitata (von Linstow, 1906) by the morphologic characteristics using light and electron microscopic observations. This is the first blindness cases of 15 horses infected with S. digitata (Nematoda: Filarioidea) in Korea.
		                        		
		                        		
		                        		
		                        			Anesthesia, Local
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Anterior Chamber
		                        			;
		                        		
		                        			Aqueous Humor
		                        			;
		                        		
		                        			Blindness*
		                        			;
		                        		
		                        			Cattle
		                        			;
		                        		
		                        			Cloaca
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Horses*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Korea
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Needles
		                        			;
		                        		
		                        			Parasites
		                        			;
		                        		
		                        			Republic of Korea*
		                        			;
		                        		
		                        			Setariasis
		                        			;
		                        		
		                        			Syringes
		                        			
		                        		
		                        	
6.Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases.
Ki Yeol KIM ; Nam Kyu KIM ; In Ho CHA ; Joong Bae AHN ; Jin Sub CHOI ; Gi Hong CHOI ; Joon Suk LIM ; Kang Young LEE ; Seung Hyuk BAIK ; Byung Soh MIN ; Hyuk HUR ; Jae Kyung ROH ; Sang Joon SHIN
Cancer Research and Treatment 2015;47(2):242-250
		                        		
		                        			
		                        			PURPOSE: Colorectal cancer patients with liver-confined metastases are classified as stage IV, but their prognoses can differ from metastases at other sites. In this study, we suggest a novel method for risk stratification using clinically effective factors. MATERIALS AND METHODS: Data on 566 consecutive patients with colorectal liver metastasis (CLM) between 1989 and 2010 were analyzed. This analysis was based on principal component analysis (PCA). RESULTS: The survival rate was affected by carcinoembryonic antigen (CEA) level (p < 0.001; risk ratio, 1.90), distribution of liver metastasis (p=0.014; risk ratio, 1.46), and disease-free interval (DFI; p < 0.001; risk ratio, 1.98). When patients were divided into three groups according to PCA score using significantly affected factors, they showed significantly different survival patterns (p < 0.001). CONCLUSION: The PCA scoring system based on CEA level, distribution of liver metastasis, and DFI may be useful for preoperatively determining prognoses in order to assist in clinical decisionmaking and designing future clinical trials for CLM treatment.
		                        		
		                        		
		                        		
		                        			Carcinoembryonic Antigen
		                        			;
		                        		
		                        			Colorectal Neoplasms
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Liver*
		                        			;
		                        		
		                        			Neoplasm Metastasis*
		                        			;
		                        		
		                        			Odds Ratio
		                        			;
		                        		
		                        			Passive Cutaneous Anaphylaxis
		                        			;
		                        		
		                        			Principal Component Analysis
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Survival Rate
		                        			
		                        		
		                        	
7.Association Analysis of TEC Polymorphisms with Aspirin-Exacerbated Respiratory Disease in a Korean Population.
Jin Sol LEE ; Joon Seol BAE ; Byung Lae PARK ; Hyun Sub CHEONG ; Jeong Hyun KIM ; Jason Yongha KIM ; Suhg NAMGOONG ; Ji On KIM ; Choon Sik PARK ; Hyoung Doo SHIN
Genomics & Informatics 2014;12(2):58-63
		                        		
		                        			
		                        			The tyrosine-protein kinase Tec (TEC) is a member of non-receptor tyrosine kinases and has critical roles in cell signaling transmission, calcium mobilization, gene expression, and transformation. TEC is also involved in various immune responses, such as mast cell activation. Therefore, we hypothesized that TEC polymorphisms might be involved in aspirin-exacerbated respiratory disease (AERD) pathogenesis. We genotyped 38 TEC single nucleotide polymorphisms in a total of 592 subjects, which comprised 163 AERD cases and 429 aspirin-tolerant asthma controls. Logistic regression analysis was performed to examine the associations between TEC polymorphisms and the risk of AERD in a Korean population. The results revealed that TEC polymorphisms and major haplotypes were not associated with the risk of AERD. In another regression analysis for the fall rate of forced expiratory volume in 1 second (FEV1) by aspirin provocation, two variations (rs7664091 and rs12500534) and one haplotype (TEC_BL2_ht4) showed nominal associations with FEV1 decline (p = 0.03-0.04). However, the association signals were not retained after performing corrections for multiple testing. Despite TEC playing an important role in immune responses, the results from the present study suggest that TEC polymorphisms do not affect AERD susceptibility. Findings from the present study might contribute to the genetic etiology of AERD pathogenesis.
		                        		
		                        		
		                        		
		                        			Aspirin
		                        			;
		                        		
		                        			Asthma
		                        			;
		                        		
		                        			Calcium
		                        			;
		                        		
		                        			Forced Expiratory Volume
		                        			;
		                        		
		                        			Gene Expression
		                        			;
		                        		
		                        			Haplotypes
		                        			;
		                        		
		                        			Logistic Models
		                        			;
		                        		
		                        			Mast Cells
		                        			;
		                        		
		                        			Phosphotransferases
		                        			;
		                        		
		                        			Polymorphism, Genetic
		                        			;
		                        		
		                        			Polymorphism, Single Nucleotide
		                        			;
		                        		
		                        			Tyrosine
		                        			
		                        		
		                        	
8.Comprehensive Variant Screening of the UGT Gene Family.
Jason Yongha KIM ; Hyun Sub CHEONG ; Byung Lae PARK ; Lyoung Hyo KIM ; Suhg NAMGOONG ; Ji On KIM ; Hae Deun KIM ; Young Hoon KIM ; Myeon Woo CHUNG ; Soon Young HAN ; Hyoung Doo SHIN
Yonsei Medical Journal 2014;55(1):232-239
		                        		
		                        			
		                        			PURPOSE: UGT1A1, UGT2B7, and UGT2B15 are well-known pharmacogenes that belong to the uridine diphosphate glucuronyltransferase gene family. For personalized drug treatment, it is important to study differences in the frequency of core markers across various ethnic groups. Accordingly, we screened single nucleotide polymorphisms (SNPs) of these three genes and analyzed differences in their frequency among five ethnic groups, as well as attempted to predict the function of novel SNPs. MATERIALS AND METHODS: We directly sequenced 288 subjects consisting of 96 Korean, 48 Japanese, 48 Han Chinese, 48 African American, and 48 European American subjects. Subsequently, we analyzed genetic variability, linkage disequilibrium (LD) structures and ethnic differences for each gene. We also conducted in silico analysis to predict the function of novel SNPs. RESULTS: A total of 87 SNPs were detected, with seven pharmacogenetic core SNPs and 31 novel SNPs. We observed that the frequencies of UGT1A1 *6 (rs4148323), UGT1A1 *60 (rs4124874), UGT1A1 *93 (rs10929302), UGT2B7 *2 (rs7439366), a part of UGT2B7 *3 (rs12233719), and UGT2B15 *2 (rs1902023) were different between Asian and other ethnic groups. Additional in silico analysis results showed that two novel promoter SNPs of UGT1A1 -690G>A and -689A>C were found to potentially change transcription factor binding sites. Moreover, 673G>A (UGT2B7), 2552T>C, and 23269C>T (both SNPs from UGT2B15) changed amino acid properties, which could cause structural deformation. CONCLUSION: Findings from the present study would be valuable for further studies on pharmacogenetic studies of personalized medicine and drug response.
		                        		
		                        		
		                        		
		                        			Asian Continental Ancestry Group/genetics
		                        			;
		                        		
		                        			European Continental Ancestry Group/genetics
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gene Frequency/genetics
		                        			;
		                        		
		                        			Glucuronosyltransferase/*genetics
		                        			;
		                        		
		                        			Haplotypes/genetics
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Linkage Disequilibrium/genetics
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Polymorphism, Single Nucleotide/*genetics
		                        			
		                        		
		                        	
9.Potential Association of DCBLD2 Polymorphisms with Fall Rates of FEV1 by Aspirin Provocation in Korean Asthmatics.
Tae Joon PARK ; Jeong Hyun KIM ; Byung Lae PARK ; Hyun Sub CHEONG ; Joon Seol BAE ; Charisse F PASAJE ; Jong Sook PARK ; Soo Taek UH ; Mi Kyeong KIM ; Inseon S CHOI ; Choon Sik PARK ; Hyoung Doo SHIN
Journal of Korean Medical Science 2012;27(4):343-349
		                        		
		                        			
		                        			Aspirin exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with nasal polyposis and aspirin hypersensitivity. The aspirin-induced bronchospasm is mediated by mast cell and eosinophilic inflammation. Recently, it has been reported that the expression of discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is up-regulated in lung cancers and is regulated by transcription factor AP-2 alpha (TFAP2A), a component of activator protein-2 (AP-2) that is known to regulate IL-8 production in human lung fibroblasts and epithelial cells. To investigate the associations between AERD and DCBLD2 polymorphisms, 12 common variants were genotyped in 163 AERD subjects and 429 aspirin tolerant asthma (ATA) controls. Among these variants, seven SNPs (rs1371687, rs7615856, rs828621, rs828618, rs828616, rs1062196, and rs8833) and one haplotype (DCBLD2-ht1) show associations with susceptibility to AERD. In further analysis, this study reveals significant associations between the SNPs or haplotypes and the percentage of forced expiratory volume in one second (FEV1) decline following aspirin challenge using multiple linear regression analysis. Furthermore, a non-synonymous SNP rs16840208 (Asp723Asn) shows a strong association with FEV1 decline in AERD patients. Although further studies for the non-synonymous Asp723Asn variation are needed, our findings suggest that DCBLD2 could be related to FEV1-related phenotypes in asthmatics.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Alleles
		                        			;
		                        		
		                        			Asian Continental Ancestry Group/*genetics
		                        			;
		                        		
		                        			Aspirin/*adverse effects
		                        			;
		                        		
		                        			Asthma, Aspirin-Induced/etiology/*genetics
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Forced Expiratory Volume/drug effects/genetics
		                        			;
		                        		
		                        			Gene Frequency
		                        			;
		                        		
		                        			Genetic Predisposition to Disease
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Haplotypes
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Membrane Proteins/*genetics
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			*Polymorphism, Single Nucleotide
		                        			;
		                        		
		                        			Regression Analysis
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
10.Potential Association of DCBLD2 Polymorphisms with Fall Rates of FEV1 by Aspirin Provocation in Korean Asthmatics.
Tae Joon PARK ; Jeong Hyun KIM ; Byung Lae PARK ; Hyun Sub CHEONG ; Joon Seol BAE ; Charisse F PASAJE ; Jong Sook PARK ; Soo Taek UH ; Mi Kyeong KIM ; Inseon S CHOI ; Choon Sik PARK ; Hyoung Doo SHIN
Journal of Korean Medical Science 2012;27(4):343-349
		                        		
		                        			
		                        			Aspirin exacerbated respiratory disease (AERD) is a clinical syndrome characterized by chronic rhinosinusitis with nasal polyposis and aspirin hypersensitivity. The aspirin-induced bronchospasm is mediated by mast cell and eosinophilic inflammation. Recently, it has been reported that the expression of discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is up-regulated in lung cancers and is regulated by transcription factor AP-2 alpha (TFAP2A), a component of activator protein-2 (AP-2) that is known to regulate IL-8 production in human lung fibroblasts and epithelial cells. To investigate the associations between AERD and DCBLD2 polymorphisms, 12 common variants were genotyped in 163 AERD subjects and 429 aspirin tolerant asthma (ATA) controls. Among these variants, seven SNPs (rs1371687, rs7615856, rs828621, rs828618, rs828616, rs1062196, and rs8833) and one haplotype (DCBLD2-ht1) show associations with susceptibility to AERD. In further analysis, this study reveals significant associations between the SNPs or haplotypes and the percentage of forced expiratory volume in one second (FEV1) decline following aspirin challenge using multiple linear regression analysis. Furthermore, a non-synonymous SNP rs16840208 (Asp723Asn) shows a strong association with FEV1 decline in AERD patients. Although further studies for the non-synonymous Asp723Asn variation are needed, our findings suggest that DCBLD2 could be related to FEV1-related phenotypes in asthmatics.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Alleles
		                        			;
		                        		
		                        			Asian Continental Ancestry Group/*genetics
		                        			;
		                        		
		                        			Aspirin/*adverse effects
		                        			;
		                        		
		                        			Asthma, Aspirin-Induced/etiology/*genetics
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Forced Expiratory Volume/drug effects/genetics
		                        			;
		                        		
		                        			Gene Frequency
		                        			;
		                        		
		                        			Genetic Predisposition to Disease
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Haplotypes
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Membrane Proteins/*genetics
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			*Polymorphism, Single Nucleotide
		                        			;
		                        		
		                        			Regression Analysis
		                        			;
		                        		
		                        			Republic of Korea
		                        			;
		                        		
		                        			Risk Factors
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail